Suppr超能文献

[急性髓系白血病的诊断与治疗]

[Diagnosis and Therapy of Acute Myeloid Leukemia].

作者信息

Medinger Michael, Heim Dominik, Halter Jörg P, Lengerke Claudia, Passweg Jakob R

机构信息

Klinik für Hämatologie, Universitätsspital Basel.

出版信息

Ther Umsch. 2019;76(9):481-486. doi: 10.1024/0040-5930/a001126.

Abstract

Diagnosis and Therapy of Acute Myeloid Leukemia Acute myeloid leukemia (AML) is a biologically complex and molecularly and clinically heterogeneous disease, and its incidence is increasing as the population ages. Cytogenetic anomalies and mutation testing remain important prognostic tools for tailoring treatment after induction therapy. Despite major advances in understanding the genetic landscape of AML and its impact on the pathophysiology and biology of the disease, as well as the rapid development of new drugs, standard treatment options have not experienced major changes during the past three decades. Allogeneic hematopoietic stem cell transplantation (HSCT) remains the best chance for cure. Here we review diagnosis and therapy of AML.

摘要

急性髓系白血病的诊断与治疗 急性髓系白血病(AML)是一种生物学复杂、分子和临床异质性的疾病,且随着人口老龄化其发病率正在上升。细胞遗传学异常和突变检测仍然是诱导治疗后制定个体化治疗方案的重要预后工具。尽管在了解AML的基因图谱及其对疾病病理生理学和生物学的影响方面取得了重大进展,以及新药迅速发展,但在过去三十年中,标准治疗方案并未发生重大变化。异基因造血干细胞移植(HSCT)仍然是治愈的最佳机会。在此,我们综述AML的诊断与治疗。

文献AI研究员

20分钟写一篇综述,助力文献阅读效率提升50倍。

立即体验

用中文搜PubMed

大模型驱动的PubMed中文搜索引擎

马上搜索

文档翻译

学术文献翻译模型,支持多种主流文档格式。

立即体验